4//SEC Filing
Avoro Capital Advisors LLC 4
Accession 0000902664-21-005078
CIK 0001042074other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:15 PM ET
Size
8.6 KB
Accession
0000902664-21-005078
Insider Transaction Report
Form 4
Avoro Capital Advisors LLC
10% Owner
Transactions
- Purchase
Pre-funded Warrant (right to buy)
2021-11-22$4.00/sh+2,500,000$9,999,750→ 2,500,000 total(indirect: See footnotes)Exercise: $0.00→ Common Stock (2,500,000 underlying)
Aghazadeh Behzad
10% Owner
Transactions
- Purchase
Pre-funded Warrant (right to buy)
2021-11-22$4.00/sh+2,500,000$9,999,750→ 2,500,000 total(indirect: See footnotes)Exercise: $0.00→ Common Stock (2,500,000 underlying)
Footnotes (3)
- [F1]Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after November 22, 2021, exercise the Pre-funded Warrant until it has been exercised in full.
- [F2]The securities reported herein are held on behalf of accounts managed by Avoro Capital Advisors LLC, a Delaware limited liability company (the "Investment Manager") and Avoro Life Sciences Fund LLC, a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager.
- [F3]The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001633313
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:15 PM ET
- Size
- 8.6 KB